Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark A Socinski

Showing results (21-30 of 279) with videos related to

Pageof 28
Sort By:
Seminars in Oncology|October 20, 2015
Incorporating Immunotherapy Into the Treatment of Non-Small Cell Lung Cancer: Practical Guidance for the ClinicMark A Socinski
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Highlights in NSCLC From the 2012 American Society of Clinical Oncology Annual MeetingMark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Alternative strategy to achieve increased overall survival and better quality of life in patients with second-line advanced non-small-cell lung cancerGary Spitzer, Mark A Socinski
Expert Review of Anticancer Therapy|July 24, 2023
Emerging agents for the treatment of advanced or metastatic NSCLC without actionable genomic alterations with progression on first-line therapyTiciana Leal, Mark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinibNirav Dhruva, Mark A Socinski
The Oncologist|March 24, 2025
Emerging molecular testing paradigms in non-small cell lung cancer management-current perspectives and recommendationsFrédérique Penault-Llorca, Mark A Socinski
The Oncologist|March 8, 2008
Considerations for second-line therapy of non-small cell lung cancerThomas E Stinchcombe, Mark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Limited-stage small-cell lung cancer: the current status of combined-modality therapyMark A Socinski, Jeffrey A Bogart
Proceedings of the American Thoracic Society|April 8, 2009
Current treatments for advanced stage non-small cell lung cancerThomas E Stinchcombe, Mark A Socinski
European Journal of Cancer (Oxford, England : 1990)|February 15, 2016
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yesLiza C Villaruz, Mark A Socinski
Pageof 28

Showing results (21-30 of 279) with videos related to

Sort By:
Pageof 28
Seminars in Oncology|October 20, 2015
Incorporating Immunotherapy Into the Treatment of Non-Small Cell Lung Cancer: Practical Guidance for the ClinicMark A Socinski
Clinical Advances in Hematology & Oncology : H&O|October 18, 2012
Highlights in NSCLC From the 2012 American Society of Clinical Oncology Annual MeetingMark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Alternative strategy to achieve increased overall survival and better quality of life in patients with second-line advanced non-small-cell lung cancerGary Spitzer, Mark A Socinski
Expert Review of Anticancer Therapy|July 24, 2023
Emerging agents for the treatment of advanced or metastatic NSCLC without actionable genomic alterations with progression on first-line therapyTiciana Leal, Mark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2009
Carcinomatous meningitis in non-small-cell lung cancer: response to high-dose erlotinibNirav Dhruva, Mark A Socinski
The Oncologist|March 24, 2025
Emerging molecular testing paradigms in non-small cell lung cancer management-current perspectives and recommendationsFrédérique Penault-Llorca, Mark A Socinski
The Oncologist|March 8, 2008
Considerations for second-line therapy of non-small cell lung cancerThomas E Stinchcombe, Mark A Socinski
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Limited-stage small-cell lung cancer: the current status of combined-modality therapyMark A Socinski, Jeffrey A Bogart
Proceedings of the American Thoracic Society|April 8, 2009
Current treatments for advanced stage non-small cell lung cancerThomas E Stinchcombe, Mark A Socinski
European Journal of Cancer (Oxford, England : 1990)|February 15, 2016
Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yesLiza C Villaruz, Mark A Socinski
Pageof 28